SpecificiT Pharma Inc. focuses on developing cellular therapies for hematological cancers that are currently untreatable with chimeric antigen receptor modified T cells (CAR-T) therapies. The company’s unique approach directs unmodified donor T-cells at Minor Histocompatibility Antigens (“MiHAs”) to safely eliminate cancer cells in patients. In addition, the company is employing a proprietary platform to discover novel tumor neoantigens that would allow this unique immunotherapy approach to be used against solid tumors.
WE FUEL HEALTH
INNOVATION.
WE FILTER HIGH
POTENTIAL
OPPORTUNITIES.
WE ARE
CANADA’S NATIONAL
HEALTH SCIENCES
ACCELERATOR.
Scroll
our impact
-
$5.0M
Amount of seed capital invested by Accel-Rx
-
$44.6M
Amount of money co-invested by external investors
-
8.9
Ratio of external funding to Accel-Rx investment
-
$4.96M
Average dollar amount per deal
-
$39.7M
Total amount of follow-on
Building a robust pipeline of health innovation companies.
Why ACCEL-RX?
We're here to ensure the health sciences ecosystem in Canada thrives today and flourishes into the future.
As Canada’s health innovation accelerator, we give health science start-ups the support they need to transcend innovations into commercialization. This means we enable companies to grow, mature and become investor-ready.
Our mission
We identify, screen, and support—through capital and expertise—promising early-stage companies developing therapeutics, medical devices, and diagnostics, so they can grow and scale to become the next generation of strong Canadian anchor companies in a globally competitive health sciences sector. We're there at that crucial fork in the road where more money is needed to reach clinical validation, but funding is scarce for early-growth capital.
Latest News
- SoundBite Medical Solutions Announces the Resignation of Steven Arless as Chairman of the Board of Directors
- Mentorship and sponsorship of young women are keys to reaching gender parity. An article by our CEO
-
Canada’s Got Talent. But We Need More Of It.
An article by our CEO -
Is Canadian Biotech Ready For The Next Industrial Revolution?
An article by our CEO
What People Say
learn more about our role in the ecosystem
about us